Precision Medicine in Pediatric Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Genetics
• Immunology

Background:

• Inflammatory bowel disease (IBD) encompasses heterogeneous chronic intestinal inflammation conditions.
• Subtypes like Crohn's disease and ulcerative colitis exhibit significant internal variability.
• Recent technological advancements, especially '-omic' data, have expanded understanding of IBD pathogenesis.

Purpose of the Study:

• To review the current state and future directions of precision medicine (PM) in pediatric IBD.
• To highlight the need for PM in optimizing limited IBD therapeutic options.
• To emphasize the utility of integrating clinical, genetic, microbial, and proteomic data for personalized treatment.

Main Methods:

• Review of recent scientific literature on IBD pathogenesis and precision medicine.
• Analysis of technological advancements in '-omic' data generation and application.
• Synthesis of current diagnostic, prognostic, and therapeutic strategies in pediatric IBD.

Main Results:

• Significant progress in understanding IBD pathogenesis driven by '-omic' data.
• Development of novel diagnostics, prognostics, and therapeutics for IBD.
• Recognition of treatment efficacy plateau despite increased therapeutic options.

Conclusions:

• Precision medicine is essential for rational selection and optimization of IBD therapies.
• Integrating multi-omic and clinical data is key to personalized pediatric IBD care.
• Future directions involve refining PM strategies for improved IBD patient outcomes.